Evidence map›Paper›PMID 25482084›Full record

ArticleBioengineered2014

Preparation and characterization of monomers to tetramers of a collagen-like domain from Streptococcus pyogenes.

Yong Y Peng, Violet Stoichevska, Linda Howell, Soren Madsen, Jerome A Werkmeister, Geoff J Dumsday, John A M Ramshaw

Abstract read
In one paragraph

Article in Bioengineered, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yong Y Penga CSIRO Manufacturing Flagship ; Clayton , Australia.
Violet Stoichevska
Linda Howell
Soren Madsen
Jerome A Werkmeister
Geoff J Dumsday
John A M Ramshaw

Funding

Biomaterial Applications of Recombinant Bacterial CollagensR01EB011620 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI BRODSKY, BARBARA M, KAPLAN, DAVID L. · 2010 to 2013
$1.3M
NIBIB NIH HHS EB011620
6 · The paper itself

Abstract

The collagen like domain Scl2 from Streptococcus pyogenes has been proposed as a potential biomedical material. It is non-cytotoxic and non-immunogenic and can be prepared in good yield in fermentation. The Scl2 collagen domain is about a quarter of the length, 234 residues, of the main collagen type, mammalian type I collagen (1014 residues) that is currently used in biomedical devices. In the present study we have made constructs comprising 1 to 4 copies of the Scl2 collagen domain, plus these same constructs with a CysCys sequence at the C-terminal, analogous to that found in mammalian type III collagens. The yields of these constructs were examined from 2 L fermentation studies. The yields of both series declined with increasing size. Circular dichroism showed that the addition of further collagen domains did not lead to a change in the melting temperature compared to the monomer domain. Addition of the CysCys sequence led to a small additional stabilization of about 2-3°C for the monomer construct when the folding (V) domain was present.

Indexed as

Bacterial ProteinsCollagenMolecular Sequence DataProtein FoldingProtein Structure, SecondaryProtein Structure, TertiaryStreptococcus pyogenesTransition TemperatureBacterial ProteinsCollagenCL, collagenous domain of the S. pyogenes collagen-like proteincollagenfermentationmelting temperatureprotein polymersrecombinantVCL, full collagen-like protein structureV, non-collagenous N-terminal domain of the S. pyogenes collagen-like protein

Identifiers

PMID25482084
PMCPMC4601231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.